Centre approves six-month BPaLM regimen for Mult-drug-resistant TB Kajal Rajput7 Sept 2024 1:45 PM ISTNew Delhi: In a move aimed at eliminating tuberculosis by 2025, five years ahead of the global target, the Union Ministry of Health & Family...
Mylan gets CDSCO panel nod to manufacture, market Pretomanid for drug resistant TB Dr. Divya Colin18 Feb 2023 6:00 PM ISTNew Delhi: Mylan Laboratories has got a go ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin bests standard-care treatment for rifampin-resistant tuberculosis Medha Baranwal22 Dec 2022 8:00 AM ISTStandard-care treatment was similarly efficacious when patients could receive it without adverse effects, according to findings from a two-stage,...
Lupin, TB Alliance parnter for anti-TB drug Pretomanid Ruchika Sharma7 Sept 2021 12:03 PM ISTMumbai: Non-profit drug developer, TB Alliance has recently granted global pharma major Lupin Limited, a non-exclusive license to manufacture the...
DCGI shows green flag to Mylan TB drug Pretomanid Ruchika Sharma23 July 2020 11:54 AM ISTThe Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Program(NTEP),...
